KMOV shares an InvestigateTV+ piece on the national weight loss trend and what coverage your insurance plan might offer. Details are thin in the clip.
Recap by typeshit. Post by @KMOV on X.
The rise was driven by new generics and steady prices, with Eli Lilly's tirzepatide named in the market breakdown.
The roundup also covers telehealth firms marketing off-label GLP-1s for addiction and a Treasury rule adding scrutiny to licensing deals with Chinese biotechs.
The GLP-1 Bridge pilot runs through 2027 and covers approved pills and shots for eligible Part D and Advantage enrollees, with no deductible.
Le Figaro reports the tablet arrives in early November. Unlike the Wegovy injection, it won't be covered by France's public reimbursement system.
In mice, GLP-1 receptor signaling mainly calmed inflammation while GLP-2 receptor signaling helped the intestine repair after T cell attack, researchers report.
The BMC resident compared the two drugs on fracture risk in people with type 2 diabetes. He presented the work at the bone research meeting in Boston.
Loading…